Meikle Phillip Terry II bought BBLG
September 28, 2026 · Form 4 insider transaction
Meikle Phillip Terry II bought 113,896 shares of Bone Biologics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
113,896
Price
$0.00
Total value
N/A
InsiderMeikle Phillip Terry II
Role—
SecurityNon-Employee Stock Option
Transaction codeA: Grant or award
Transaction dateSeptember 28, 2026
Filing dateSeptember 30, 2026
Shares owned after113,896
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests infour equal quarterly installments.